Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression.
Yu-Ching FanKuan-Der LeeYuan-Chin TsaiPublished in: Biomedicines (2020)
Our results support TILs/CD11b- cells being able to protect androgen-dependent cells from inflammatory damage and promote the malignant progression of prostate cancers partly through the IL1RN in the TME.